Table 2 Correlation of circ-NOLC1 expression with different clinicopathological features of ovarian carcinoma.
Clinicopathological features | N | circ-NOLC1 expression/18 s | P value |
|---|---|---|---|
The pathology types | Â | Â | 0.2795 |
   Serous carcinoma | 86 | 2.20741E-05 ± 6.38584E-05 |  |
   The other pathology types | 32 | 1.58183E-05 ± 4.60309E-05 |  |
Age | Â | Â | 0.2531 |
   ≤52 | 62 | 2.38226E-05 ± 6.41964E-05 |  |
   >52 | 56 | 1.65634E-05 ± 5.39825E-05 |  |
CA125 | Â | Â | 0.0029 |
   ≤35 U/ml | 9 | 3.97132E-06 ± 6.6421E-06 |  |
   >35 U/ml | 109 | 2.17322E-05 ± 6.16323E-05 |  |
FIGO stages | Â | Â | 0.0144 |
   I | 22 | 6.29372E-06 ± 1.94561E-05 |  |
   II–IV | 96 | 2.36051E-05 ± 6.48809E-05 |  |
Pathology classification | Â | Â | 0.0018 |
   Well | 18 | 3.39141E-06 ± 9.26029E-06 |  |
   Mod + poor | 100 | 2.34351E-05 ± 6.40101E-05 |  |